USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 157 filers reported holding USANA HEALTH SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 60 | -50.0% | 0.00% | -100.0% |
| Q2 2020 | $8,000 | -93.4% | 120 | -99.1% | 0.00% | -83.3% |
| Q1 2020 | $122,000 | +12100.0% | 13,793 | +12106.2% | 0.01% | – |
| Q3 2019 | $1,000 | -50.0% | 113 | -85.9% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 800 | +14.3% | 0.00% | – |
| Q1 2019 | $3,000 | – | 700 | +600.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 100 | -92.9% | 0.00% | -100.0% |
| Q3 2018 | $85,000 | -28.0% | 1,400 | -17.6% | 0.01% | -33.3% |
| Q2 2018 | $118,000 | +218.9% | 1,700 | -46.9% | 0.01% | +200.0% |
| Q1 2018 | $37,000 | +1750.0% | 3,200 | +60.0% | 0.00% | – |
| Q4 2017 | $2,000 | -98.7% | 2,000 | -67.0% | 0.00% | -100.0% |
| Q3 2017 | $159,000 | +381.8% | 6,069 | +12.4% | 0.01% | +500.0% |
| Q2 2017 | $33,000 | – | 5,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |